Back to filter

Related topics

Factors Affecting Petri Dish Condensation in Tissue Culture (CU) Chambers

Percival Scientific

Nov 29, 2023

In this report, we will investigate the effects of infrared lighting, light intensity, stacking, as well as constant...

Visualization of spatial distribution of hemoglobin with various oxygen saturations in small animals


Nov 28, 2023

With the aid of our uniquely developed device and analysis software, our primary objective is to map the spatial...

A fluorescent reporter system for anaerobic thermophiles

COY laboratory products

Nov 27, 2023

Anaerobic microorganisms are key effectors for the sustainable production of biofuels and biochemicals, as they...

Vizgen webinar: spatial relationships in Developmental Biology


Nov 21, 2023

MERFISH integrates spatial transcriptomics technology with high resolution spatial imaging, In this webinar we will...

ACCELA educational webinar: Drive key insights and discoveries with new live cell analysis applications for eSight

Agilent technologies

Nov 14, 2023

The xCELLigence RTCA eSight enables simultaneous real time biosensor impedance-based and...

NanoCellect webinar: Plant Potential - Gentle Cell Sorting for Enhanced Plant Biology Workflows


Nov 3, 2023

Gentle cell sorting is a useful tool to increase the efficiency of plant biology workflows that include gene...

Single Cell Deposition: the cornerstone of Flow Cytometry for cellular analysis and manipulation


Nov 2, 2023

One notable technology for harnessing the power of single cell deposition is the NanoCellect WOLF G2 Cell Sorter and N1...

Single cell genotypic and phenotypic analysis of residual disease in acute myeloid leukemia

Mission Bio

Nov 1, 2023

Measurable residual disease (MRD), defined as the population of cancer cells which persists following therapy, serves...

Emulate in vivo conditions – introduce shear flow to your experiments with BioFlux system

Fluxion Biosciences

Oct 31, 2023

Most research is still conducted in vitro without the presence of flow. We use the BioFlux System to give you the...

Validation of an orthotopic non-small cell lung cancer mouse model to use in radiotherapy studies

Precision X-Ray

Oct 30, 2023

The use of pre-clinical orthotopic mouse models is essential for the development of novel therapies targeting solid...

Show all topics (10)

SIMOA-based analysis of plasma NFL levels in MCI and AD patients

Nov 3, 2023

Alzheimer’s disease (AD) is widely recognized as the most common etiology of dementia [1] and is currently ranked as the sixth most prevalent cause of mortality in the United States. The global prevalence of AD is expected to rise to 135 million individuals by the year 2050 [1].

There is currently no definitive diagnostic test or biomarker for the disease, which means that diagnosis often involves ruling out other causes of cognitive decline [2]. Several biomarkers have been identified that can potentially be used for diagnosing AD in its early stages. The four main biomarkers found in cerebrospinal fluid (CSF), i.e., amyloid beta (Aβ)1–42, Aβ42/40 ratio, Tau, and phosphorylated-Tau (p-Tau)181, are reliable for supporting AD diagnosis as they indicate the hallmark AD pathologies of amyloidosis and neurodegeneration [3]. Although these CSF biomarkers are reliable for supporting AD diagnostics, the process of collecting CSF can be inconvenient for subjects and may cause procedural efforts. This prevents their use as a screening item in initial, asymptomatic subjects and makes repetitive monitoring of the disease progression challenging. Therefore, there is a significant necessity to develop blood-based markers that can provide targeted and fairly noninvasive screening tests in the right context of clinical application

Read more

Scientific paper

Get more info

Sylwia Królikowska

Office assistant



+48 222 668 736

Send Message

Brand profile


Simoa technology is changing the way in which the biology of health and disease is studied by giving researchers the ability to closely examine critical biomarkers.

Related products

The Simoa HD-1 Analyzer is a fully automated instrument for running immunoassays using the Quanterix single molecule array, or Simoa platform.

show detail

Technology for robust multiplex circulating biomarker detection at the earliest stages of disease progression - even at healthy baseline levels.

show detail

The SR-X is designed for ultra-sensitive multiplex detection of up to six analytes per well, with low volume requirements to increase productivity and throughput, while conserving your precious samples.

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic